AIM1 Inhibitors
Chemical inhibitors of AIM1 can affect the protein's function through various molecular pathways. Wortmannin and LY294002, both phosphoinositide 3-kinase (PI3K) inhibitors, can disrupt the signaling pathways that regulate apoptosis, potentially leading to an increase in cell death and a consequent decrease in AIM1 levels due to the reduced number of cells expressing it. Moreover, LY294002 prevents the activation of proteins downstream of the PI3K pathway, potentially resulting in diminished AIM1 function. Similarly, Dasatinib, a Src family kinase inhibitor, and PP2, a selective inhibitor of Src kinases, can alter cellular processes such as adhesion and migration where AIM1 is implicated. By inhibiting Src kinases, these compounds can affect the regulation of the cytoskeleton and thereby potentially influence AIM1's role in cytoskeletal dynamics.
The MAPK/ERK pathway, which influences cell proliferation and differentiation, can also be inhibited by specific chemicals to modulate AIM1 activity. U0126 and PD98059, both MEK inhibitors, prevent the activation of the MAPK/ERK pathway, potentially hindering AIM1's involvement in cell cycle progression and differentiation. Another MAPK pathway component, the c-Jun N-terminal kinase (JNK), can be inhibited by SP600125, which may impact AIM1's role in cell proliferation and apoptosis. Additionally, SB203580, a specific inhibitor of p38 MAPK, can affect AIM1's role in cellular responses to stress and cytokines by inhibiting this stress-related pathway. The ROCK pathway, which is implicated in cellular functions such as contraction, motility, and apoptosis, can be inhibited by Y-27632, potentially affecting AIM1's function in these processes. Lastly, Go6983 and Bisindolylmaleimide I, both PKC inhibitors, along with GF109203X, which is synonymous with Bisindolylmaleimide I, can inhibit signaling pathways regulating cell survival and apoptosis, potentially impacting the function of AIM1 in these pathways.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3K), which are involved in various signaling pathways, including those that regulate apoptosis. Inhibition of PI3K can lead to an increase in apoptosis, which may result in decreased levels of AIM1 due to the loss of cells expressing this protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that prevents the phosphorylation and activation of proteins downstream of the PI3K pathway. As AIM1 is implicated in cellular differentiation processes that can be PI3K-dependent, inhibition of this pathway may result in reduced function of AIM1. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor. As Src kinases can phosphorylate a wide range of substrates and are involved in various signaling pathways, inhibition of these kinases can alter cell adhesion and migration processes where AIM1 might play a role. This may lead to functional inhibition of AIM1 activity in cellular processes. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family kinases. By inhibiting Src kinases, PP2 can disrupt signaling pathways that contribute to the regulation of the cytoskeleton, which may affect the function of AIM1 in cytoskeletal dynamics. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of mitogen-activated protein kinase (MAPK) kinase (MEK), which is part of the MAPK/ERK pathway. This pathway can influence cell proliferation and differentiation, processes where AIM1 might be involved. Inhibition of MEK and thereby the MAPK/ERK pathway can hinder AIM1 functionality. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is another MEK inhibitor that prevents the activation of the MAPK/ERK pathway. By blocking this pathway, it could lead to an inhibition of AIM1's role in cell cycle progress and differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is part of the MAPK pathway. JNK influences cell proliferation, apoptosis, and other cellular functions. Inhibition of JNK might therefore inhibit AIM1's role in these cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. The p38 MAPK pathway is involved in response to stress and inflammation. Inhibiting this pathway can hinder the role of AIM1 in cellular responses to stress and cytokines. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of the Rho-associated protein kinase (ROCK). The ROCK pathway is implicated in various cellular functions including contraction, motility, proliferation, and apoptosis, any of which could involve AIM1. Inhibition of ROCK may thus inhibit AIM1's function in these processes. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a pan-protein kinase C (PKC) inhibitor. Since PKC is involved in a multitude of signaling pathways, including those regulating cell survival and apoptosis, Go6983 can inhibit these pathways and potentially inhibit the functional processes involving AIM1. | ||||||